Latest Capital Raising News

Lucapa Diamond Company Limited reported a robust Q1 2025 with a 74% increase in diamond grade at Lulo and a 36% revenue rise, while advancing its stake in the Lulo JV to 51%. Exploration at Merlin in Australia revealed significant new targets, setting the stage for further growth.

Australian Rare Earths Limited (ASX: AR3) has successfully raised $3.6 million through a fully subscribed rights issue, backed strongly by existing shareholders and directors. The capital injection positions AR3 to advance uranium exploration and rare earth development amid favorable geopolitical shifts.

QMines Limited reports a 42% increase in Indicated resources at Develin Creek following maiden drilling, completes a $4 million capital raise, and moves to acquire the Mount Mackenzie gold-silver project, signaling a strategic expansion in Queensland.

Sparc Technologies has progressed to Stage 2 of its Sparc Hydrogen joint venture with pilot plant commissioning slated for mid-2025, while also securing its first patent for photocatalytic water splitting technology in Morocco. Concurrently, its graphene-based additive ecosparc® demonstrates promising field trial results, underpinning commercial momentum.

Zoom2u Technologies reports steady group revenue with Locate2u growing 10%, supported by AI initiatives that cut staff costs and a $0.5 million capital raise.

Golden Mile Resources is set to commence its maiden drilling program at the Pearl Copper Project in Arizona, following significant gold and silver assays at the newly identified Aurora Prospect. The company has secured key federal permits, marking a pivotal step in its US exploration campaign.

Sunshine Metals has made significant progress at its Ravenswood Consolidated Project with encouraging drilling results on shallow oxide gold targets and new gold-copper prospects, supported by a $3 million placement to fund further exploration.

Toubani Resources has raised A$29 million through a strategic placement led by A2MP Investments, which also commits to a US$160 million debt facility, positioning the Kobada Gold Project for a final investment decision by late 2025.

Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.

Adherium Limited reports a surge in US commercial patients for its Hailie Smartinhaler platform, alongside strategic hires and a new product launch compatible with AstraZeneca inhalers, underpinning plans for a capital raise.

Impact Minerals Limited reported a solid cash position of A$3.75 million at quarter-end, supported by a recent equity raise that extends its funding runway to nearly four quarters despite ongoing exploration expenditures.

CZR Resources has terminated its prior deal with Miracle Iron and endorsed a superior A$75 million cash offer from the Rio Tinto-led Robe River Iron Associates JV for its Robe Mesa Project. The company retains promising gold and titanium-vanadium assets while preparing for shareholder approval.